GE Healthcare LLC Announces Recall of SIGNA Premier Systems
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
GE Healthcare LLC is voluntarily recalling 41 SIGNA Premier systems due to potential risks from ferrous fittings that could cause injury during servicing.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 14, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
GE Healthcare LLC is recalling SIGNA Premier systems because they may have been manufactured or serviced with ferrous fittings instead of non-ferrous ones. This could result in the fittings being attracted by the magnetic field if the system is accessed during service, potentially leading to personnel injury.
Which Products Are Affected
The affected products are SIGNA Premier systems, with a total quantity of 41 units. The systems include the following codes: UDI-DI/GTIN: 00840682135269, 00195278010797; System ID: 415353UMR2, 415723SHMR19, 413253MR3T, 908725MR, 609652MR3T, M48823, 7168453T, 513584MR5, 513636EASTMR, 513636T1MR, 605333MRPRM, 832522CRMR1, 703858PRE2, 804675VA3T, 082427110162, 082427220143, 082427020147, 082427200242, 082427160461, 082427250139, 082427140382, M4216469, 353745MR01, GON5655515, KRMR56474971, KRMR56203791, KRMR55433661, KRMR56344161, KRMR55774051, KRMR55914661, NOMRI26833321, 15974045, GON1882380, ESMRI27056983, ESMRI26960129, A203MR06, 690120MR01, 11524261, VNMRI26792525, VNMRI26592248, VNMRI26809677. Distribution was nationwide in the United States, specifically in the states of CA, MA, NJ, NY, OH, SD, TX, VA, and PR, as well as worldwide in countries including Sweden, Switzerland, United Kingdom, Vietnam, China, Norway, Portugal, Spain, France, Germany, Greece, Korea, Republic of. The recall number is Z-1767-2026.
What You Should Do
Consumers should contact the recalling firm, GE Healthcare LLC, for information on this recall, as it was initiated voluntarily by the firm.
Why This Matters
This recall affects medical devices used for diagnostic imaging and highlights potential safety risks in healthcare equipment manufacturing, which could impact personnel safety during servicing.
Source
FDA recall database: https://www.fda.gov/ (Attribution: FDA, Recall Number Z-1767-2026)
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,865 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 14, 2026.
Frequently Asked Questions
Common questions about this FDA recall.